Table of Contents

1 Migraine Market: Executive Summary
2 Table of Contents
2.1 List of Tables
2.2 List of Figures
3 Migraine Market: Market Characterization
3.1 Overview
3.2 Migraine Market Size
3.3 Migraine Market Forecast and CAGR
3.4 Drivers and Barriers for Migraine Market
3.4.1 Drivers for Migraine Market
3.4.2 Barriers for Migraine Market
3.5 Opportunity and Unmet Need
3.6 Key Takeaway
4 Migraine Market: Competitive Assessment
4.1 Overview
4.2 Strategic Competitor Assessment
4.3 Product Profiles of the Major Marketed Products
4.3.1 Overview
4.3.2 Efficacy
4.3.3 Safety Profile
4.3.4 Pricing
4.3.5 Clinical Study Details
4.4 Key Takeaway
5 Migraine Market: Pipeline Assessment
5.1 Overview
5.2 Strategic Pipeline Assessment
5.2.1 Technology Trends Analytical Framework
5.3 Migraine Therapeutics – Promising Drugs under Clinical Development
5.4 Molecule Profiles of Promising Drugs under Clinical Development
5.4.1. Overview
5.4.2 Efficacy
5.4.3 Safety
5.4.4 Clinical Study Details
5.5 Migraine Therapeutics Market – Clinical Pipeline by Mechanism of Action
5.6 Migraine Pipeline – Pipeline by Clinical Phases of Development
5.6.1 Migraine Therapeutics – Phase III Clinical Pipeline
5.6.2 Migraine Therapeutics – Phase II Clinical Pipeline
5.6.3 Migraine Therapeutics – Phase I Clinical Pipeline
5.6.4 Migraine Therapeutics – Preclinical Pipeline
5.6.5 Migraine Therapeutics – Discovery Pipeline
5.7 Discontinued / Suspended Drugs for Migraine
5.8 Key Takeaway
6 Migraine Market: Implications for Future Market Competition
7 Migraine Market: Future Players in Migraine Market
8 Migraine Market: Appendix
8.1 Definitions
8.2 Acronyms
8.3 Research Methodology
8.3.1 Coverage
8.3.2 Secondary Research
8.3.3 Forecasting
8.3.3.1 Epidemiology-based Forecasting
8.3.4 Primary Research
8.3.5 Expert Panel validation
8.4 Contact Us
8.5 Disclaimer
8.6 Sources
List of Tables

Table 1: Global Migraine Treatment by Stage of the Disease, 2009
Table 2: Global Migraine Therapeutics Market, Revenue Forecasts ($ m), 2000-2008
Table 3: Global Migraine Therapeutics Market, Revenue Forecasts ($ m), 2009-2015
Table 4: Major marketed products comparison in Migraine, 2009
Table 5: Migraine Therapeutics – Most Promising Drugs Under Clinical Development, 2009
Table 6: Migraine Therapeutics – Phase III Clinical Pipeline, 2009
Table 7: Migraine Therapeutics – Phase II Clinical Pipeline, 2009
Table 8: Migraine Therapeutics – Phase I Clinical Pipeline, 2009
Table 9: Migraine Therapeutics – Preclinical Pipeline, 2009
Table 10: Migraine Therapeutics – Drug Discovery Pipeline, 2009
Table 11: Migraine Therapeutics – List of Discontinued Drugs, 2009 List of Figures

Figure 1: Global Migraine Therapeutics Market Forecast, 2000-2015
Figure 2: Migraine Therapeutics Market – Opportunity and Unmet Need, 2009
Figure 3: Migraine Therapeutics Market – Strategic Competitor Assessment, 2009
Figure 4: Technology Trends Analytic Framework of the Migraine Pipeline, 2009
Figure 5: Technology Trends Analytic Framework of the Migraine Pipeline – Description, 2009
Figure 6: Migraine Therapeutics Market – Clinical Pipeline by Mechanism of Action, 2009
Figure 7: Migraine Pipeline by Phase of Clinical Development, 2009
Figure 8: Migraine Therapeutics Market – Strategic Competitor Assessment, 2009
Figure 9: Migraine Therapeutics Market – Clinical Pipeline by Company, 2009
Figure 10: Methodology
Figure 11: Market Forecasting Model